Skip to main content
Kindstar Globalgene Technology, Inc. logo

Kindstar Globalgene Technology, Inc. — Investor Relations & Filings

Ticker · 9960 ISIN · KYG5262E1044 HKEX Human health and social work activities
Open in API
Filings indexed 602 across all filing types
Latest filing 2025-02-04 Share Issue/Capital Cha…
Country HK Hong Kong
Listing HKEX 9960

About Kindstar Globalgene Technology, Inc.

http://www.kindstar.com.cn

Kindstar Globalgene Technology, Inc. is a leading independent provider of advanced specialty clinical testing services, specializing in esoteric testing. The company maintains the largest esoteric testing portfolio in its market, utilizing internationally-advanced laboratory facilities for clinical testing, scientific research, and applied R&D. Its comprehensive testing menu, featuring over 100 items, covers critical diagnostic areas including hematology, genetic diseases, gynecology, infectious diseases, neurology, and oncology. These services provide physicians and patients access to specialized diagnostics crucial for the diagnosis and treatment of major diseases.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2025
Share Issue/Capital Change Classification · 80% confidence The document is a statutory monthly return (Form FF301) filed to the Hong Kong Exchange detailing movements in authorised share capital, issued shares, treasury shares, share options, and other capital changes for the month ended 31 January 2025. It is not an earnings release, annual or interim report, nor is it a management announcement or proxy solicitation. It specifically reports new share issues and changes in capital structure under the listing rules, fitting the "Share Issue/Capital Change" category (SHA).
2025-02-04 English
Next Day Disclosure Returns
Share Issue/Capital Change Classification · 94% confidence The document is the HKEX “Next Day Disclosure Return” (Form FF305) detailing changes in issued shares under Main Board Rule 13.25A/GEM Rule 17.27A. It provides transaction details for an allotment and issuance of new shares under the general mandate (59,431,356 shares at HKD 1.42), with opening and closing balances of issued and treasury shares. This is a regulatory announcement of a share capital change (new issue of shares), matching the “Share Issue/Capital Change” category.
2025-01-24 English
DISCLOSEABLE TRANSACTION - COMPLETION OF ACQUISITION OF EQUITY INTEREST IN THE TARGET COMPANIES
M&A Activity Classification · 92% confidence The document is a corporate announcement by a Hong Kong listed issuer regarding the completion of an acquisition transaction, issuance of shares as consideration, changes in shareholding structure, and an amendment agreement. It is not a full annual or interim report, nor is it a simple dividend, board change or earnings release. It clearly relates to an M&A activity (a disclosable transaction under HKEx rules). Therefore, it falls under M&A Activity (Code: TAR).
2025-01-24 English
Change of Address of Principal Place of Business in Hong Kong
Regulatory Filings Classification · 89% confidence This is a brief announcement (well under 5,000 characters) notifying shareholders and the market of a change in the company’s Hong Kong principal business address. It is not reporting financial results, a director change, share transactions, dividends, or issuing any detailed report; nor does it fit any more specific category. Therefore it falls into the general regulatory announcement category (RNS).
2025-01-06 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2024
Regulatory Filings Classification · 85% confidence The document is a standardized monthly return (Form FF301) submitted to the Hong Kong Exchanges and Clearing Limited under Chapter 19B Listing Rules, detailing movements in authorised, issued, and treasury share capital for the month ended 31 December 2024. It is a routine regulatory submission rather than an earnings release, annual or interim report, or investor presentation. It does not announce a specific corporate action (such as a new share issuance or dividend) but instead serves as a compliance filing. This fits the fallback category for general regulatory filings.
2025-01-02 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2024
Regulatory Filings Classification · 92% confidence The document is a Form FF301 monthly return filed by a Hong Kong listed issuer to the Hong Kong Exchanges & Clearing Limited, detailing movements in authorised share capital, issued shares, treasury shares, share options, etc. This is a routine regulatory compliance filing under HKEX Listing Rules (Chapter 19B) rather than an earnings release, financial report, M&A announcement, or other specific category. It fits the fallback category for general regulatory filings. Therefore, it should be classified as RNS (Regulatory Filings).
2024-12-02 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.